ijms-logo

Journal Browser

Journal Browser

Cancers: Drug Design, Development and Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 132

Special Issue Editor

Retired Academic, School of Medical Sciences, The University of Sydney, Sydney, Australia
Interests: metal based anticancer drugs; tumour active phytochemicals; synergism; combination index; proteomics; artificial intelligence
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As the name suggests, this Special Issue will focus on drug design, development and therapy. Although cancer is the most dreaded disease of our time, significant advancements have made in drug design, delivery and modes of treatment. In addition, over two hundred diseases with common characteristics of uncontrolled growth and metastasis are now termed as cancer. While significant progress has been achieved for treatment against certain cancers, some other cancers remain much more challenging. The two main problems in cancer are acquired drug resistance and side effects. Recent studies show that synergistic combinations of targeted therapy with tumour active phytochemicals can offer an effective means of overcoming drug resistance and reducing the side effects. It should also be noted that artificial intelligence (AI) is increasingly used in cancer diagnosis and treatment. So, in this volume, we invite research papers and reviews on drug development, therapy and modes of treatments applied to all forms of cancers.

Dr. Fazlul Huq
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • combination therapy
  • acquired resistance
  • proteomics
  • AI

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop